Concentration-QT analysis of the randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects
Crossref DOI link: https://doi.org/10.1007/s10928-015-9461-x
Published Online: 2016-01-06
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mehta, Rashmi
Green, Michelle
Patel, Bela
Wagg, Jonathan
Funding for this research was provided by:
GSK
Text and Data Mining valid from 2016-01-06